Bone and cardiovascular health GLP-1RAs influence bone metabolism by promoting bone formation and reducing resorption, potentially mitigating osteoporosis risk
Currently, there is no official contraindication to its use in IBD patients in FDA labeling, but specific clinical trial data addressing this population is limited
A thiophosphorylated derivative showed no reaction under the same conditions (Figure 13A)
Increasing evidence suggests a strong pathophysiological connection between AD and Diabetes Mellitus Type II (DM2), which is characterized by insulin resistance and subsequent pancreatic islet -cell failure, leading to insufficient insulin levels for normal glucose metabolism 3,4,5,6
Meanwhile, Novo Nordisk faces new lawsuits filed by people who experienced severe side effects and disease after using Rybelsus